Atossa Therapeutics Inc. (ATOS)
NASDAQ: ATOS
· Real-Time Price · USD
0.78
-0.00 (-0.01%)
At close: Aug 15, 2025, 1:17 PM
Atossa Therapeutics Fail-to-Deliver
Total FTD Shares
75.77K
Below Average
FTD / Avg. Volume
6.51%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Atossa Therapeutics Inc. has
75,772
shares failed to deliver, representing 6.51%
of the average daily volume of
1,163,177
shares. Over the past year, the monthly average FTD is
8,230
shares, with the current level 821% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 0.9366 | 75.77K | +4951.47% |
| Jun 30, 2025 | 0.83 | 1.5K | -93.99% |
| May 29, 2025 | 0.7605 | 24.98K | +2397.80% |
| Apr 30, 2025 | 0.8979 | 1K | -91.57% |
| Mar 26, 2025 | 0.6963 | 11.86K | +144.75% |
| Feb 28, 2025 | 0.7657 | 4.85K | +3872.95% |
| Jan 31, 2025 | 0.8419 | 122 | -75.60% |
| Dec 31, 2024 | 0.9441 | 500 | -50.00% |
| Nov 20, 2024 | 1.2 | 1K | +99900.00% |
| Oct 31, 2024 | 1.38 | 1 | -99.44% |
| Sep 30, 2024 | 1.52 | 178 | -96.44% |
| Aug 30, 2024 | 1.37 | 5K | +163.01% |
| Jul 29, 2024 | 1.4 | 1.9K | -61.69% |
| Jun 27, 2024 | 1.14 | 4.97K | +4040.00% |
| May 31, 2024 | 1.3 | 120 | -77.98% |
| Apr 30, 2024 | 1.51 | 545 | -72.71% |
| Mar 28, 2024 | 1.8 | 2K | -75.95% |
| Feb 27, 2024 | 1.03 | 8.3K | +585.23% |
| Jan 31, 2024 | 0.854 | 1.21K | +60500.00% |
| Dec 08, 2023 | 0.7532 | 2 | -98.67% |
| Nov 30, 2023 | 0.74 | 150 | -98.30% |
| Oct 31, 2023 | 0.67 | 8.84K | +112.16% |
| Sep 27, 2023 | 0.768 | 4.17K | +69366.67% |
| Aug 10, 2023 | 1.03 | 6 | -99.81% |
| Jul 31, 2023 | 1.1 | 3.23K | -77.37% |
| Jun 29, 2023 | 1.28 | 14.27K | +20287.14% |
| May 31, 2023 | 0.93 | 70 | -30.00% |
| Apr 24, 2023 | 0.67 | 100 | -6.54% |
| Mar 31, 2023 | 0.72 | 107 | -97.88% |
| Feb 28, 2023 | 0.74 | 5.06K | +994.59% |
| Jan 27, 2023 | 0.82 | 462 | n/a |